DexCom, Inc.
DXCM
Hisse Senetlerindeki Sıralama
#761
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Hisse Fiyatı
$85.51
Piyasa Değeri
$32.27B
Değişim (1 gün)
-0.55%
Değişim (1 yıl)
24.95%
Ülke
US
Ticaret DexCom, Inc. (DXCM)
Kategori
Healthcare
DexCom, Inc. (DXCM) için tedavüldeki hisse sayısı
June 2026 itibarıyla tedavüldeki hisse sayısı: 383.70M
DexCom, Inc. şirketinin son finansal raporlarına ve hisse fiyatına göre, mevcut tedavüldeki hisse sayısı 383.70M'dir. December 2024 sonunda şirketin 404.63M tedavüldeki hissesi vardı. Tedavüldeki hisse sayısı genellikle hisse bölünmeleri ve hisse geri alımları ile etkilenir.
DexCom, Inc. (DXCM) için 2000 - 2026 tarihleri arasındaki hisse geçmişi
Her yıl sonunda tedavüldeki hisse sayısı
| Yıl | Tedavüldeki Hisse Sayısı | Değiştir |
|---|---|---|
| 2026 (TTM) | 383.70M | -1.67% |
| 2025 | 390.20M | -3.57% |
| 2024 | 404.63M | 4.83% |
| 2023 | 386.00M | -0.87% |
| 2022 | 389.40M | 0.65% |
| 2021 | 386.90M | 2.46% |
| 2020 | 377.60M | 3.62% |
| 2019 | 364.40M | 3.29% |
| 2018 | 352.80M | 2.20% |
| 2017 | 345.20M | 3.23% |
| 2016 | 334.40M | 4.76% |
| 2015 | 319.20M | 6.12% |
| 2014 | 300.80M | 5.77% |
| 2013 | 284.40M | 3.49% |
| 2012 | 274.80M | 4.73% |
| 2011 | 262.40M | 15.29% |
| 2010 | 227.60M | 28.31% |
| 2009 | 177.39M | 50.40% |
| 2008 | 117.95M | 4.15% |
| 2007 | 113.25M | 3.95% |
| 2006 | 108.94M | 43.77% |
| 2005 | 75.78M | 728.71% |
| 2004 | 9.14M | 5.35% |
| 2003 | 8.68M | 6.05% |
| 2002 | 8.18M | 7.89% |
| 2001 | 7.59M | 9.81% |
| 2000 | 6.91M | 0.00% |
Benzer şirketler veya rakipler için tedavüldeki hisse sayısı
| Şirket | Tedavüldeki Hisse Sayısı | Fark | Ülke |
|---|---|---|---|
| 1.74B | 354.27% |
US
|
|
| 1.28B | 234.14% |
IE
|
|
| 383.50M | -0.05% |
US
|
|
| 1.48B | 285.09% |
US
|
|
| - | - |
DE
|
